JEREMY STEVENS: Open Payments
NPI 1063919843 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 10 payments from 7 companies in 2025. Trend: 2023 $45 · 2024 $167 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $181 |
| PFIZER INC. | 1 | $28 |
| Lilly USA, LLC | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: Ozempic, Wegovy, PREVNAR 20, MOUNJARO, XIFAXAN, GEMTESA, SHINGRIX, VOQUEZNA.
Industry payments across WA — which companies pay providers there.
